title: Incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium 201 imaging in patients with ST-T abnormalities on their resting electrocardiograms.
abstract: BACKGROUND
  The incremental prognostic value of thallium 201 imaging in patients with nonspecific ST-T abnormalities on the resting electrocardiogram (ECG) may be different from those with a normal resting ECG.
  
  
  METHODS
  Nine hundred thirty-nine consecutive patients with nonspecific ST-T abnormalities on their resting ECG who had undergone exercise 201 Tl imaging were followed for a median duration of 7.0 y (94% complete). The Cox proportional hazards regression model was used in a stepwise fashion to generate (1) a clinical (Cl) model, (2) a clinical and exercise (Cl + Ex) model, (3) and a clinical, exercise, and thallium (Cl + Ex + Tl) model, for the prediction of cardiac death.
  
  
  RESULTS
  Age, sex, and diabetes composed the Cl model (chi2 = 63, P < .0001). The Duke treadmill score added to the Cl + Ex model (chi2 = 71, P < .0001). Increased lung uptake (P < .0001) added significantly and summed reversibility score ( P = .03) added modestly to the Cl + Ex + Tl model (chi2 = 96, P < .0001). On the basis of the Cl + Ex + Tl model, the low-, intermediate-, and high-risk groups had a 7-y survival free of cardiac death of 99%, 88%, and 58%, respectively (P < .0001). Using the Cl + Ex + Tl model, only a small number of low-risk and high-risk patients by the Cl + Ex model were reclassified. However, 48% of the 230 patients in the intermediate-risk group by the Cl + Ex model were reclassified as low risk or high risk.
  
  
  CONCLUSIONS
  201 Tl imaging has incremental prognostic value in patients with nonspecific abnormalities on their resting ECG. However, patients classified as low risk or high risk by exercise testing using the Cl + Ex model do not require 201 Tl imaging. Intermediate-risk patients should be further risk-stratified by 201 Tl imaging.
authors.affiliation: Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.
authors.forename: Jennifer M F
authors.initials: JM
authors.lastname: Kwok
authors.forename: Timothy F
authors.initials: TF
authors.lastname: Christian
authors.forename: Todd D
authors.initials: TD
authors.lastname: Miller
authors.forename: David O
authors.initials: DO
authors.lastname: Hodge
authors.forename: Raymond J
authors.initials: RJ
authors.lastname: Gibbons
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000000981:diagnostic imaging*; D006331:Heart Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D013794:Thallium Radioisotopes; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D013794:Thallium Radioisotopes